Chernajovsky Y - Search Results

1

Human single-chain variable fragment that specifically targets arthritic cartilage.

Hughes C, Faurholm B, Dell'Accio F, Manzo A, Seed M, Eltawil N, Marrelli A, Gould D, Subang C, Al-Kashi A, De Bari C, Winyard P, Chernajovsky Y, Nissim A. Hughes C, et al. Among authors: chernajovsky y. Arthritis Rheum. 2010 Apr;62(4):1007-16. doi: 10.1002/art.27346. Arthritis Rheum. 2010. PMID: 20131274 Free PMC article.

2

Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.

Nissim A, Winyard PG, Corrigall V, Fatah R, Perrett D, Panayi G, Chernajovsky Y. Nissim A, et al. Among authors: chernajovsky y. Arthritis Rheum. 2005 Dec;52(12):3829-38. doi: 10.1002/art.21479. Arthritis Rheum. 2005. PMID: 16329077 Free article.

3

Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmid.

Gould DJ, Bright C, Chernajovsky Y. Gould DJ, et al. Among authors: chernajovsky y. Arthritis Res Ther. 2004;6(2):R103-13. doi: 10.1186/ar1036. Epub 2003 Dec 22. Arthritis Res Ther. 2004. PMID: 15059273 Free PMC article.

4

Novel delivery methods to achieve immunomodulation.

Gould DJ, Chernajovsky Y. Gould DJ, et al. Among authors: chernajovsky y. Curr Opin Pharmacol. 2007 Aug;7(4):445-50. doi: 10.1016/j.coph.2007.05.002. Epub 2007 Jul 3. Curr Opin Pharmacol. 2007. PMID: 17611159 Free PMC article. Review.

5

Advances in understanding the genetic basis of rheumatoid arthritis and osteoarthritis: implications for therapy.

Chernajovsky Y, Winyard PG, Kabouridis PS. Chernajovsky Y, et al. Am J Pharmacogenomics. 2002;2(4):223-34. doi: 10.2165/00129785-200202040-00002. Am J Pharmacogenomics. 2002. PMID: 12421093 Review.

6

Endogenous GATA factors bind the core sequence of the tetO and influence gene regulation with the tetracycline system.

Gould DJ, Chernajovsky Y. Gould DJ, et al. Among authors: chernajovsky y. Mol Ther. 2004 Jul;10(1):127-38. doi: 10.1016/j.ymthe.2004.04.011. Mol Ther. 2004. PMID: 15233949 Free article.

7

Gene therapy for autoimmune diseases: quo vadis?

Chernajovsky Y, Gould DJ, Podhajcer OL. Chernajovsky Y, et al. Nat Rev Immunol. 2004 Oct;4(10):800-11. doi: 10.1038/nri1459. Nat Rev Immunol. 2004. PMID: 15459671 Review.

8

The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation.

Inglis JJ, Nissim A, Lees DM, Hunt SP, Chernajovsky Y, Kidd BL. Inglis JJ, et al. Among authors: chernajovsky y. Arthritis Res Ther. 2005;7(4):R807-16. doi: 10.1186/ar1743. Epub 2005 Apr 12. Arthritis Res Ther. 2005. PMID: 15987482 Free PMC article.

9

Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation.

Yousaf N, Gould DJ, Aganna E, Hammond L, Mirakian RM, Turner MD, Hitman GA, McDermott MF, Chernajovsky Y. Yousaf N, et al. Among authors: chernajovsky y. Arthritis Rheum. 2005 Sep;52(9):2906-16. doi: 10.1002/art.21268. Arthritis Rheum. 2005. PMID: 16142754 Free article.

10

Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis.

Gould D, Yousaf N, Fatah R, Subang MC, Chernajovsky Y. Gould D, et al. Among authors: chernajovsky y. Arthritis Res Ther. 2007;9(1):R7. doi: 10.1186/ar2113. Arthritis Res Ther. 2007. PMID: 17254348 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters